UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Celltrion’s biosimilar takes 30% of Europe market share
Celltrion’s second antibody biosimilar product in Europe, Truxima, has regi...
by Constance Williams
|
2017-08-01 16:31
라인
5 universities publish most papers in prestigious bio journals
Which university has published the largest number of bio-related research p...
by Nam Doo-hyun
|
2017-08-01 16:18
라인
Medipost hits record sales in Q2
Medipost announced record sales in the second quarter of 2017 and positive ...
by Marian Chu
|
2017-08-01 10:00
라인
Celltrion applies for FDA approval of new anticancer biosimilar
Celltrion Healthcare is preparing to release its third biosimilar Herzuma i...
by Constance Williams
|
2017-07-31 15:04
라인
Samsung Bioepis, Merck launches biosimilar in US
Samsung Bioepis will launch its autoimmune disease biosimilar Renflexis (in...
by Marian Chu
|
2017-07-25 11:27
라인
Nature Cell to unveil stem cell drug for Alzheimer's disease
Biotechnology enterprise Nature Cell네이처셀 successfully administered “AstroSt...
by Constance Williams
|
2017-07-20 16:41
라인
Sillajen wins approval to start clinical trial in China
The China Food and Drug Administration (CFDA) has given the green light to ...
by Marian Chu
|
2017-07-20 13:43
라인
‘Stem cell therapy’s problem? No hit item yet’
Stem cells, which can be transplanted into a human body and differentiating...
by Nam Doo-hyun
|
2017-07-19 18:16
라인
Smaller firms lead domestic stem cell market
Big businesses and small- to medium-sized enterprises (SMEs) account for 17...
by Nam Doo-hyun
|
2017-07-05 13:49
라인
Janssen director points out flaws in Korean quality systems
“We need to provide a gap in quality systems and quality management for vac...
by Constance Williams
|
2017-06-30 17:09
라인
David and Goliath; how Korean pharmaceuticals should compete with multinational giants
When foreign experts look at the Korean pharmaceutical industry, they wonde...
by Marian Chu
|
2017-06-29 09:44
라인
Korean, US firms tie up to bring in Alzheimer treatment
DuchemBio Co. (CEO: Kim Jong-woo), the first Korean company that produced d...
by Constance Williams
|
2017-06-28 17:51
라인
Medytox’s overseas exchange program helps global advances
Medytox Inc. (CEO Jung Hyun-ho), Korea's largest maker of botulinum tox...
by Constance Williams
|
2017-06-28 16:43
라인
‘Global Bio Conference 2017’ opens for 3-day run at COEX
The “Global Bio Conference 2017 (GBC 2017)” kicked off its annual conferenc...
by Marian Chu
|
2017-06-28 16:30
라인
KISTI present ways to sharpen competitiveness of precision medicine
For precision medicine to take root in Korea, the nation needs to make a mo...
by Nam Doo-hyun
|
2017-06-23 13:35
라인
‘Korea needs to develop biomarkers for personalized medical services’
As the biomarker technology remains at a nascent stage in Korea, the indust...
by Nam Doo-hyun
|
2017-06-22 13:24
라인
'Bio ventures are for developing new drugs, not making cosmetics'
Bio ventures promoting cosmetic products while claiming to carry the banner...
by Nam Doo-hyun
|
2017-06-19 14:47
라인
New government set to streamline healthcare R&D projects
The Moon Jae-in administration, which is busy setting up specific strategie...
by Nam Doo-hyun
|
2017-06-15 11:05
라인
Sewon Cellontech’s cartilage-restoring device wins Europe‘s patent
Sewon Cellontech has completed its patent registration in 35 countries in E...
by Constance Williams
|
2017-06-08 17:28
라인
Government publishes report on ‘genome editing’
The Ministry of Food and Drug Safety published a report Thursday on “genome...
by Constance Williams
|
2017-06-08 15:47
-
이전
31
32
33
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top